Abstract:1371 Objectives Because of their unique properties including large surface area, versatile chemistry, and low toxicity, graphene-based materials are versatile platforms for cancer imaging and therapy. Our goal was to employ nanographene oxide (GO) for in vivo tumor vasculature targeting, and to quantitatively evaluate the tumor targeting efficacy with PET using 64Cu as the radiolabel. Methods GO sheets, with amino group-terminated branched PEG covalently attached to the surface, were conjugated to NOTA (for 64Cu labeling) and VEGF121 (a naturally occurring protein that bind to VEGFR, a vascular marker of tumor angiogenesis). NOTA conjugated GO, without VEGF121, was also synthesized as the control. FACS analysis, size measurements, and serum stability studies were performed to characterize the GO conjugates. Serial PET imaging and biodistribution studies were carried out to evaluate the tumor targeting efficacy and pharmacokinetics in xenograft U87MG tumor-bearing mice, which express high level of VEGFR on the tumor vasculature but not on the tumor cells. Imaging results were validated by histology. Results NOTA-GO-VEGF121 had sizes of ~20-100 nm and exhibited VEGFR specificity and superb stability in vitro and in vivo. Serial PET imaging showed rapid and persistent uptake of 64Cu-NOTA-GO-VEGF121 (6.5±1.7, 8.2±1.4, 7.7±1.4, 5.7±0.8, and 4.7±0.7 %ID/g at 0.5, 3, 6, 16, and 24 post-injection; n=4) in U87MG tumor, several fold higher than non-targeted control (i.e. 64Cu-NOTA-GO), which was confirmed by bio-D. Flow cytometry and histological examination confirmed the specificity of 64Cu-NOTA-GO-VEGF121 for tumor vascular VEGFR targeting, with little extravasation. Conclusions 64Cu-NOTA-GO-VEGF121 was able to target vascular VEGFR efficiently in mouse models, which gave an extra boost to tumor uptake based on passive targeting alone. The significantly improved tumor targeting efficiency of GO realized in this work may be utilized for future PET image-guided cancer-targeted drug/gene delivery in vivo, to further enhance the therapeutic efficacy and to enable cancer theranostics.

Receptor-targeting Fluorescence Imaging and Theranostics Using a Graphene Oxide Based Supramolecular Glycocomposite

Covalent RGD-graphene-phthalocyanine Nanocomposite for Fluorescence Imaging-Guided Dual Active/passive Tumor-Targeted Combinatorial Phototherapy.

Fluorogenic probing of specific recognitions between sugar ligands and glycoprotein receptors on cancer cells by an economic graphene nanocomposite.

WE-C-217BCD-06: in Vivo Targeting and Imaging of Tumor Vasculature with Radiolabeled, Antibody-Conjugated Nano-Graphene.

Intracellular Imaging with A Graphene-Based Fluorescent Probe

Theranostic GO-based Nanohybrid for Tumor Induced Imaging and Potential Combinational Tumor Therapy.

In Vivo Targeting and Positron Emission Tomography Imaging of Tumor Vasculature with (66)Ga-Labeled Nano-Graphene.

Aptamer-mediated nanocomposites of semiconductor quantum dots and graphene oxide as well as their applications in intracellular imaging and targeted drug delivery

A Graphene Oxide-Based Fluorescent Biosensor for the Analysis of Peptide-Receptor Interactions and Imaging in Somatostatin Receptor Subtype 2 Overexpressed Tumor Cells.

An Insight into Graphene Oxide Associated Fluorogenic Sensing of Glycodye-Lectin Interactions.

Graphene nanoribbon-based supramolecular ensembles with dual-receptor targeting function for targeted photothermal tumor therapy

In Vivo Targeting And Imaging Of Tumor Vasculature With Radiolabeled, Antibody-Conjugated Nano-Graphene

Fluorescent Phthalocyanine-Graphene Conjugate with Enhanced NIR Absorbance for Imaging and Multi-Modality Therapy

Interlocked supramolecular glycoconjugated polymers for receptor-targeting theranostics

Targeted Multimodal Theranostics Via Biorecognition Controlled Aggregation of Metallic Nanoparticle Composites.

Targeted Raman Imaging Of Cells Using Graphene Oxide-Based Hybrids

Dual Engineering Interface-Driven Complementary Graphene Oxide-Protein Dimer Supramolecular Architecture Enables Nucleus Imaging and Therapy

In Vivo Tumor Vasculature Targeting and Imaging with Vegf-Conjugated Nanographene Oxide

Graphene Oxide Based Surface-Enhanced Raman Scattering Probes For Cancer Cell Imaging

Fluorescence Dye Loaded Nano-Graphene For Multimodal Imaging Guided Photothermal Therapy

Graphene Oxide Based Fluorescent Nanocomposites for Cellular Imaging